0
0
Your Cart
    Your cart is emptyReturn to Shop
    Free shipping on all orders over $100 (US) and $300 (International)10% discount on crypto payments support@swisschemzlab.com

    Swiss Chems Bioregulator

    Showing 12 of 12 products
    Sale
    Bronchogen, 20mg

    Bronchogen,

    20mg
    Earn 129 Reward Points
    Original price was: $70.00.Current price is: $64.95.
    Cardiogen, 20mg

    Cardiogen,

    20mg
    Earn 127 Reward Points
    $63.95
    Sale
    Cartalax, 20mg

    Cartalax,

    20mg
    Earn 123 Reward Points
    Original price was: $70.00.Current price is: $61.95.
    Chonluten, 20mg

    Chonluten,

    20mg
    Earn 117 Reward Points
    $58.99
    Sale
    Cortagen, 20mg

    Cortagen,

    20mg
    Earn 93 Reward Points
    Original price was: $65.00.Current price is: $46.95.
    Livagen, 20mg

    Livagen,

    20mg
    Earn 125 Reward Points
    $62.95
    Sale
    Ovagen, 20mg

    Ovagen,

    20mg
    Earn 115 Reward Points
    Original price was: $65.00.Current price is: $57.50.
    Sale
    Pancragen, 20mg

    Pancragen,

    20mg
    Earn 119 Reward Points
    Original price was: $65.00.Current price is: $59.95.
    Pinealon, 20mg

    Pinealon,

    20mg
    Earn 115 Reward Points
    $57.95
    Prostamax, 20mg

    Prostamax,

    20mg
    Earn 119 Reward Points
    $59.95
    Testagen, 20mg

    Testagen,

    20mg
    Earn 119 Reward Points
    $59.95
    Sale
    Thymogen, 20mg

    Thymogen,

    20mg
    Earn 135 Reward Points
    Original price was: $80.95.Current price is: $67.95.

    Swiss Chems Bioregulator

    Explore the Value Savers Bundle collection from Swiss Chems, featuring selected research compounds grouped into convenient, cost-conscious bundle formats. Browse available combinations for controlled laboratory investigations and comparative research. For research use only—not for human consumption.

    All Swiss Chems products are supplied for laboratory research use only. They are not for human or veterinary use.

    Subscribe to receive our latest news

    85% of users stay up-to-date with our newsletter